Evidence map›Paper›PMID 35456923›Full record

ArticleInternational journal of molecular sciences2022

Development of Viral-Vectored Vaccines and Virus Replicon Particle-Based Neutralisation Assay against Mayaro Virus.

Young Chan Kim, Arlen-Celina Lücke, César López-Camacho, Beate Mareike Kümmerer, Arturo Reyes-Sandoval

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Antivirals and Vaccines.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Young Chan KimThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford OX3 7BN, UK.ORCID 0000-0003-2847-9407
Arlen-Celina LückeInstitute of Virology, Medical Faculty, University of Bonn, 53127 Bonn, Germany.
César López-CamachoThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford OX3 7BN, UK.ORCID 0000-0001-7932-2341
Beate Mareike KümmererInstitute of Virology, Medical Faculty, University of Bonn, 53127 Bonn, Germany.ORCID 0000-0002-9011-2764
Arturo Reyes-SandovalThe Jenner Institute, Nuffield Department of Medicine, University of Oxford, The Henry Wellcome Building for Molecular Physiology, Roosevelt Drive, Oxford OX3 7BN, UK.ORCID 0000-0002-2648-1696
University of Oxford · GBUniversity of Bonn · DE

Funding

European Union's Horizon 2020 research and innovation 734548Innovate UK 94851-557155
6 · The paper itself

Abstract

Mayaro virus (MAYV) is an emerging alphavirus causing acute febrile illness associated with chronic polyarthralgia. Although MAYV is currently restricted to tropical regions in South America around the Amazon basin, it has the potential to spread globally by

Indexed as

Alphavirus InfectionsChikungunya virusViral VaccinesAnimalsAntibodies, ViralMammalsMiceRepliconAntibodies, ViralViral VaccinesadenovirusChikungunya virusenzyme-linked immunosorbent assay (ELISA)immunogenicityMayaro virusMVAneutralisation assayvaccineviral-vectored

Identifiers

PMID35456923
PMCPMC9026931
OpenAlexW4224214706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.